Novo Nordisk A/S (NONOF)
126.26
+3.76
(+3.07%)
USD |
OTCM |
Apr 22, 16:00
Novo Nordisk Total Assets (Quarterly): 40.97B for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 40.97B |
March 31, 2023 | 36.60B |
December 31, 2022 | 34.72B |
September 30, 2022 | 32.10B |
June 30, 2022 | 30.74B |
March 31, 2022 | 29.58B |
December 31, 2021 | 29.61B |
September 30, 2021 | 27.16B |
June 30, 2021 | 25.30B |
March 31, 2021 | 22.29B |
December 31, 2020 | 23.95B |
September 30, 2020 | 22.07B |
June 30, 2020 | 20.53B |
March 31, 2020 | 18.65B |
December 31, 2019 | 18.83B |
September 30, 2019 | 18.30B |
June 30, 2019 | 17.96B |
March 31, 2019 | 16.55B |
December 31, 2018 | 16.97B |
September 30, 2018 | 15.85B |
June 30, 2018 | 16.02B |
March 31, 2018 | 15.47B |
December 31, 2017 | 16.49B |
September 30, 2017 | 15.49B |
June 30, 2017 | 15.05B |
Date | Value |
---|---|
March 31, 2017 | 13.53B |
December 31, 2016 | 13.87B |
September 30, 2016 | 13.14B |
June 30, 2016 | 13.20B |
March 31, 2016 | 12.52B |
December 31, 2015 | 13.45B |
September 30, 2015 | 12.85B |
June 30, 2015 | 12.22B |
March 31, 2015 | 11.23B |
December 31, 2014 | 12.58B |
September 30, 2014 | 12.15B |
June 30, 2014 | 11.65B |
March 31, 2014 | 11.64B |
December 31, 2013 | 13.02B |
September 30, 2013 | 12.33B |
June 30, 2013 | 11.23B |
March 31, 2013 | 10.73B |
December 31, 2012 | 11.64B |
September 30, 2012 | 11.54B |
June 30, 2012 | 10.21B |
March 31, 2012 | 10.95B |
December 31, 2011 | 11.27B |
September 30, 2011 | 11.32B |
June 30, 2011 | 11.94B |
March 31, 2011 | 11.17B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.96B
Minimum
Jun 2019
40.97B
Maximum
Jun 2023
26.43B
Average
25.30B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
Eli Lilly and Co | 64.01B |
Amgen Inc | 97.15B |
Pfizer Inc | 226.50B |
AstraZeneca PLC | 101.12B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 27.77B |
Shareholders Equity (Quarterly) | 13.20B |
Debt to Equity Ratio | 0.2841 |
Current Ratio | 0.8783 |
Net Debt Paydown Yield | 0.00% |